上海皓元医药股份有限公司, 0.2% 28nov2030, CNY (Conv.)
国内债券, 浮动利率, 可交换的
国内债券, 浮动利率, 可交换的
|
Shanghai Haoyuan Pharmaceutical Co., Ltd., established in 2006 and listed on the STAR Market (stock code: 688131), is primarily engaged in providing CRO and CDMO services for small molecule and novel drug modalities to the global ...
Shanghai Haoyuan Pharmaceutical Co., Ltd., established in 2006 and listed on the STAR Market (stock code: 688131), is primarily engaged in providing CRO and CDMO services for small molecule and novel drug modalities to the global pharmaceutical and biotech industry. The company specializes in research, development, and production of pharmaceutical building blocks, intermediates, APIs, and formulations with an integrated service platform covering the entire drug development process.
|
| Step-up/Step-down |
|
|
|
|
|
|
|
|
探索最全面的数据库
1 000 000
债券
80 234
股票
175 910
ETF & Funds
8万
指数
以最有效的方式跟踪您的投资组合